Verona Pharma plc (I9SA) — Financial Flexibility Index
Verona Pharma plc (I9SA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of €30.56 Million (operating CF €30.56 Million minus capex €0.00) represents 0% of total liabilities (€294.60 Million). Check how strategically is Verona Pharma plc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verona Pharma plc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Verona Pharma plc across 9 annual periods. See Verona Pharma plc (I9SA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Verona Pharma plc (2016–2024)
Year-by-year free cash flow to debt coverage for Verona Pharma plc. For the full company profile including market capitalisation, see I9SA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | €-121.62 Million | €-122.20 Million | €269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | €-50.22 Million | €-50.22 Million | €58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | €-59.83 Million | €-59.86 Million | €29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | €-33.24 Million | €-33.25 Million | €38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | €-44.99 Million | €-45.08 Million | €19.35 Million | ▲ +19.8% |
| 2019 | -2.90x | €-42.81 Million | €-42.87 Million | €14.78 Million | ▼ -130.1% |
| 2018 | -1.26x | €-18.10 Million | €-18.11 Million | €14.37 Million | ▲ +20.8% |
| 2017 | -1.59x | €-20.69 Million | €-20.70 Million | €13.00 Million | ▼ -322.1% |
| 2016 | -0.38x | €-5.43 Million | €-5.59 Million | €14.40 Million | — |